EUVIMEDEUVIMED entdecken
Crossref

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

Chen-Di Han, Chun-Chun Wang iD, Li Huang, Xing Chen iD

Briefings in Bioinformatics · 2023

DOI: 10.1093/bib/bbad215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2023. Verfasst von Chen-Di Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Neural Networks, Computer. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adverse drug–drug interactions (DDIs) have become an increasingly serious problem in the medical and health system. Recently, the effective application of deep learning and biomedical knowledge graphs (KGs) have improved the DDI prediction performance of computational models. However, the problems of feature redundancy and KG noise also arise, bringing new challenges for researchers. To overcome these challenges, we proposed a Multi-Channel Feature Fusion model for multi-typed DDI prediction (MCFF-MTDDI). Specifically, we first extracted drug chemical structure features, drug pairs’ extra label features, and KG features of drugs. Then, these different features were effectively fused by a multi-channel feature fusion module. Finally, multi-typed DDIs were predicted through the fully connected neural network. To our knowledge, we are the first to integrate the extra label information into KG-based multi-typed DDI prediction; besides, we innovatively proposed a novel KG feature learning method and a State Encoder to obtain target drug pairs’ KG-based features which contained more abundant and more key drug-related KG information with less noise; furthermore, a Gated Recurrent Unit-based multi-channel feature fusion module was proposed in an innovative way to yield more comprehensive feature information about drug pairs, effectively alleviating the problem of feature redundancy. We experimented with four datasets in the multi-class and the multi-label prediction tasks to comprehensively evaluate the performance of MCFF-MTDDI for predicting interactions of known-known drugs, known-new drugs and new-new drugs. In addition, we further conducted ablation studies and case studies. All the results fully demonstrated the effectiveness of MCFF-MTDDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNeural Networks, ComputerHumansDrug InteractionsResearch Personnel

Stichwörter der Autor:innen

Gated Recurrent UnitState Encoderbiomedical knowledge graphdrug–drug interactionmulti-channel feature fusion

Autor:innen und Institutionen

  • School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China.
  • School of Science, Jiangnan University, Wuxi, 214122, China.
  • The Future Laboratory, Tsinghua University, Beijing, 100084, China.
  • Artificial Intelligence Research Institute, China University of Mining and Technology, Xuzhou, 221116, China.

ORCID-Profile: Chun-Chun Wang, Xing Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Han, C. D., Wang, C. C., Huang, L., & Chen, X. (2023). MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbad215

Vancouver

Han CD, Wang CC, Huang L, Chen X. MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction. Briefings in Bioinformatics. 2023. doi:10.1093/bib/bbad215

BibTeX
@article{Han2023,
  author = {Han, Chen-Di and Wang, Chun-Chun and Huang, Li and Chen, Xing},
  title = {MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction},
  journal = {Briefings in Bioinformatics},
  year = {2023},
  doi = {10.1093/bib/bbad215}
}
Kostenlos starten →